28 Jun, 2024 The evolving landscape of patent term extensions By Rebecca Lawrence Petros Nafpliotis Part 1: Supplementary Protection Certificates – harmonisation Following the European elections earlier this month, innovator’s eyes are...
28 Jun, 2024 Pride in Life Sciences Series 2024 By Alexandra de Zwart Ruth Faragher To mark Pride Month 2024, we have launched a new series to celebrate the LGBTQ+ community working in the life sciences sector. Visibility...
18 Jun, 2024 New Belgian law on raw materials used by pharmacists By Jean-Christophe Top On the 27th of May 2024, the new law of February 29, 2024 on raw materials used by pharmacists was published in the Belgian Official...
12 Jun, 2024 The European Health Data Space – What lies ahead? By Andreas Rüdiger In the middle of March 2024, the Council of the European Union and the European Parliament reached a deal on a provisional agreement for...
11 Jun, 2024 Femtech and the use of AI By Linzi Penman Naomi Pryde Sarah Cunningham Kirsty McKay +1 more... Show less Due to an exponential growth in the investment in female health and wellbeing, Forbes and Dealroom reported that 2023 saw 1.14 billion...
11 Jun, 2024 Life Sciences News in Italy: May 2024 By DLA Piper Life Sciences This month, our specialist life sciences team in Italy covers the key issues in the sector, including: Regulatory; White Collar Crime and...
10 Jun, 2024 Poland - Life Sciences Monthly Brief, May 2024 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our May monthly briefing, which covers key updates and insights in the following areas: Medicinal products;Medical...
07 Jun, 2024 DLA Piper Life Sciences Index 2024 By Lyndsey Hudson Marco de Morpurgo Welcome to the first edition of the Life Sciences Index, a study about perceptions of innovation and growth in the life sciences...
05 Jun, 2024 MHRA statement describing draft policy for international recognition of medical devices By Ataikor Ngerebara Charlotte Doyle On 21 May 2024, the Medicines & Healthcare products Regulatory Agency (“MHRA”) issued a Statement of Policy Intent on International...